Abstract:Significance: Optical imaging has accelerated neuroscience in recent years. Genetically encoded fluorescent activity sensors of calcium, neurotransmitters, and voltage are commonly used for optical recording of neuronal activity. However, fluorescence imaging is limited to superficial regions for in vivo activity imaging, due to photon scattering and absorbance. Bioluminescence imaging offers a promising alternative for achieving activity imaging in deeper brain regions without hardware implanted within the brain. Bioluminescent reporters can be genetically encoded and produce photons without external excitation. The use of enzymatic photon production also enables prolonged imaging sessions without the risk of photobleaching or phototoxicity, making bioluminescence suitable for non-invasive imaging of deep neuronal populations.Aim: To facilitate the adoption of bioluminescent activity imaging, we sought to develop a low cost, simple in vitro method that simulates in vivo conditions to optimize imaging parameters for determining optimal exposure times and optical hardware configurations to determine what frame rates can be captured with an individual lab's imaging hardware with sufficient signal-to-noise ratios without the use of animals prior to starting an in vivo experiment.Approach: We developed an assay for modeling in vivo optical conditions with a brain tissue phantom paired with engineered cells that produce bioluminescence. We then used this assay to limit-test the detection depth versus maximum frame rate for bioluminescence imaging at experimentally relevant tissue depths using off-the-shelf imaging hardware.Results: We developed an assay for modeling in vivo optical conditions with a brain tissue phantom paired with engineered cells that produce bioluminescence. With this method, we demonstrate an effective means for increasing the utility of bioluminescent tools and lowering the barrier to adoption of bioluminescence activity imaging.Conclusions: We demonstrated an improved method for optimizing imaging parameters for activity imaging in vivo with bioluminescent sensors.

Optimizing live-cell fluorescence imaging conditions to minimize phototoxicity

Phototoxicity in live fluorescence microscopy, and how to avoid it

Recent Research on Stimulated Emission Depletion Microscopy for Reducing Photobleaching

New approaches for low phototoxicity imaging of living cells and tissues

Assessing phototoxicity in live fluorescence imaging

Harnessing Artificial Intelligence To Reduce Phototoxicity in Live Imaging

Quantification of cellular phototoxicity of organelle stains by the dynamics of microtubule polymerization

Synchronous Photoactivation-Imaging Fluorophores Break Limitations of Photobleaching and Phototoxicity in Live-cell Microscopy

Between life and death: strategies to reduce phototoxicity in super-resolution microscopy

Optimising image capture for low-light widefield quantitative fluorescence microscopy

PhotoFiTT: A Quantitative Framework for Assessing Phototoxicity in Live-Cell Microscopy Experiments

Supercontinuum intrinsic fluorescence imaging heralds ‘free view’ of living systems

Gentle rhodamines for live-cell fluorescence microscopy

High Spatiotemporal Resolution and Low Photo-Toxicity Fluorescence Imaging in Live Cells and in Vivo.

Near-Infrared Spontaneously Blinking Fluorophores for Live Cell Super-Resolution Imaging with Minimized Phototoxicity

Potential consequences of phototoxicity on cell function during live imaging of intestinal organoids

Shedding light on imaging safety: Decoding the origin of photocytotoxicity in RhB‐assisted fluorescence imaging

Method for optimizing imaging parameters to record neuronal and cellular activity at depth with bioluminescence